DPH5 could promote glucose uptake and consumption of IR-HepG2 cells, accelerate glucose utilization, and improve insulin resistance and insulin sensitivity by regulating PI3K/AKT-GSK3β signaling pathway and increasing the expression of GLUT4 and GSK3β proteins (Zhang et al., 2022). The gene discussed is SLC2A4; the disease is Insulin resistance.